免疫性隐形类主导了卵巢癌的抗原景观

相关实验视频

Updated: May 27, 2025

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Remya Raja¹, Kiran K Mangalaparthi², Anil K Madugundu²

¹Department of Immunology, Mayo Clinic, Phoenix, AZ, USA.

Science advances

|February 19, 2025

概括

研究人员发现,来自非编码DNA的神秘在卵巢癌 (OC) 中具有免疫性. 这些激活CD8+T细胞,表明它们是重要的癌症抗原,用于更好的预后.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

卵巢癌 (OC) 中CD3+和CD8+T细胞透率增加与患者预后改善相关.
驱动OC中这种抗瘤免疫反应的特定抗原在很大程度上仍未确定.
新出现的证据表明,HLA类I可以呈现来自非编码基因组区域 (密码性) 的.

研究的目的:

调查来自OC中非编码转录的神秘的免疫性.
在OC样本中识别和表征由HLA类I呈现的神秘.
评估这些神秘的潜力作为瘤抗原.

主要方法:

在五个转移性OC样本上进行了免疫基分析和RNA测序.
呈现的的识别和量化,包括来自非编码区域的神秘.
评估T细胞激活 (4-1BB和IFN-γ表达) 在自异性CD8+T细胞在优先级密码刺激后.

主要成果:

在五个OC样本中确定了311个神秘,平均每名患者40-83个.
尽管丰度低 (总的<1%),但来自非编码转录的神秘是占主导地位的抗原类.
几乎70%的优先级密码诱导了自主CD8+T细胞中显著的T细胞激活.

结论:

非编码的密码代表了卵巢癌中抗原的显著和免疫性类别.
这些发现强调了密码性的潜力,作为OC免疫治疗的新目标.
密码性的免疫性需要进一步研究,以便在OC中进行治疗开发.

更多相关视频

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

相关概念视频

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.